A total of 100 million doses of two COVID-19 vaccines developed by subsidiaries of Sinopharm have been distributed globally, said one of the subsidiaries on March 26. On March 22, Sinovac Biotech said it had supplied 160 million doses of its COVID-19 vaccine to 18 countries and regions, including China, with over 70 million shots injected.  
The three vaccines, along with a fourth vaccine from CanSino Biologics Inc., have been approved in China and other countries for general public use.